Whitehawk Therapeutics Inc
WHWK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $25,983 | $24,354 | $15,216 | $1,120 |
| % Growth | 6.7% | 60.1% | 1,258.6% | – |
| Cost of Goods Sold | $54,054 | $51,738 | $33,997 | $19,670 |
| Gross Profit | -$28,071 | -$27,384 | -$18,781 | -$18,550 |
| % Margin | -108% | -112.4% | -123.4% | -1,656.3% |
| R&D Expenses | $51,030 | $48,929 | $32,662 | $19,670 |
| G&A Expenses | $0 | $0 | $0 | $18,511 |
| SG&A Expenses | $36,749 | $44,549 | $40,176 | $18,511 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$48,392 | -$48,929 | -$28,938 | $54,486 |
| Operating Expenses | $39,387 | $44,549 | $43,900 | $92,667 |
| Operating Income | -$67,458 | -$71,933 | -$62,681 | -$111,217 |
| % Margin | -259.6% | -295.4% | -411.9% | -9,930.1% |
| Other Income/Exp. Net | $3,767 | $6,168 | $2,168 | $1,129 |
| Pre-Tax Income | -$63,691 | -$65,765 | -$60,513 | -$110,088 |
| Tax Expense | $0 | $0 | $0 | $2 |
| Net Income | -$63,691 | -$65,765 | -$60,513 | -$110,090 |
| % Margin | -245.1% | -270% | -397.7% | -9,829.5% |
| EPS | -2.36 | -2.44 | -2.69 | -12.41 |
| % Growth | 3.3% | 9.3% | 78.3% | – |
| EPS Diluted | -2.36 | -2.44 | -2.69 | -12.41 |
| Weighted Avg Shares Out | 27,030 | 26,918 | 22,511 | 8,871 |
| Weighted Avg Shares Out Dil | 27,030 | 26,918 | 22,511 | 8,923 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,925 | $6,400 | $2,398 | $13 |
| Interest Expense | $154 | $231 | $230 | $665 |
| Depreciation & Amortization | $193 | $169 | $159 | $105 |
| EBITDA | -$64,627 | -$71,764 | -$58,798 | -$36,956 |
| % Margin | -248.7% | -294.7% | -386.4% | -3,299.6% |